Home » Topics » BioWorld Science

BioWorld Science
RSS

Hungarian scientists patent myosin-2 ATPase activity inhibitors

Nov. 7, 2019

Chinese researchers present new p300 HAT inhibitors

Nov. 7, 2019

VTCN1 gene linked to schizophrenia in Chinese families

Nov. 7, 2019

Thomas Helledays Stiftelse foer Medicinsk Forskning divulges MTHFD2 inhibitors

Nov. 7, 2019

U.K. researchers patent BCL-6 inhibitors

Nov. 7, 2019

Bristol-Myers Squibb presents new MGAT2 inhibitors

Nov. 7, 2019

Lilly opens phase I study of LY-3435151 in advanced solid tumors

Nov. 7, 2019

Retrotope initiates phase II/III study of RT-001 in Friedreich's ataxia

Nov. 7, 2019

New phase I trial explores BI-1701963 in KRAS-mutated advanced or metastatic solid tumors

Nov. 7, 2019

Boehringer Ingelheim reports data on new SOS1-KRAS interaction inhibitors for cancer

Nov. 7, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...